Delivery of multiple PspA fragments by CyaA toxoid induces broad protection against Streptococcus pneumoniae

Abstract

Streptococcus pneumoniae is a leading cause of lower respiratory tract (LRT) infections and invasive pneumococcal diseases (IPD). Conjugate vaccines are effective against IPD and nasal colonization but offer coverage limited to serotypes included in the formulations. Pneumococcal surface protein A (PspA) stands out as a promising vaccine antigen. We had previously shown that recombinant adenylate cyclase toxoid from Bordetella pertussis (CyaA) carrying PspA fragments induces humoral responses and protection against pneumococcal infection in mice. Here, we present an optimized construct combining fragments derived from four PspA variants (CyaA-A2-A4/A1-A3).Immunization of mice with CyaA-A2-A4/A1-A3 conferred protection against IPD and promoted a rapid control of LRT infection. Antibody reactivity and protection were observed across strains expressing distinct PspAs and capsular serotypes. Importantly, CyaA-A2-A4/A1-A3 protected mice against serotype 3 isolates from clonal complex 180, a major clone causing disease worldwide. CyaA-A2-A4/A1-A3 may be proposed as a complementary vaccine to induce broad protection against pneumococcal infections.

StIA is a Novel Nucleoid-Associated Protein of Streptococcus pneumoniae that Activates DNA Topoisomerase I
A. A. de Vasconcelos Junior, P. Herrera, A. G. de la Campa +1
bioRxiv11 Sep 2026PreprintAll rights reservedFull textMicrobiologybioRxiv
Genome-wide mapping of genetic suppression events in Streptococcus pneumoniae
Clement Jun Wei Ng, Justin J. Zik, Yifan Li +6
Nature Communications22 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsCrossref
Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella.
Sara N Stoner, Eric D Larson, Sam Fulte +5
Proceedings of the National Academy of Sciences of the United States of America7 Oct 2026Peer-reviewedCC BYFull text1 citedImmunologyEurope PMC
Mechanism of NanR transcriptional activation of sialic acid metabolism in Streptococcus pneumoniae.
David M Wood, Ashleigh S Johns, Zachary D Tillett +11
Nucleic acids research1 Sep 2026Peer-reviewedCC BYFull textGenetics & genomicsEurope PMC
Real-time near-infrared imaging distinguishes nasopharyngeal colonization from aspiration of Streptococcus pneumoniae and identifies aspiration as a trigger of severe disease
T. Saito, M. Kobayashi, Z. Sun +6
bioRxiv21 Aug 2026PreprintCC BYFull textMicrobiologybioRxiv

Cite

BibTeX RIS

BibTeX

@article{carneiro2026delivery,
  title = {{Delivery of multiple PspA fragments by CyaA toxoid induces broad protection against Streptococcus pneumoniae}},
  author = {Giovanna B Carneiro and Marilyne Davi and Giuliana S Oliveira and Katharyne Chinaia and Ashleigh Howard and Dima El Safadi and Daniela M Ferreira and Eliane N Miyaji and Daniel Ladant and Maria Leonor S. Oliveira},
  journal = {Scientific Reports},
  year = {2026},
  month = aug,
  doi = {10.1038/s41598-026-67702-8},
  url = {https://pasteur.hal.science/pasteur-05835783v1},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Delivery of multiple PspA fragments by CyaA toxoid induces broad protection against Streptococcus pneumoniae
AU  - Giovanna B Carneiro
AU  - Marilyne Davi
AU  - Giuliana S Oliveira
AU  - Katharyne Chinaia
AU  - Ashleigh Howard
AU  - Dima El Safadi
AU  - Daniela M Ferreira
AU  - Eliane N Miyaji
AU  - Daniel Ladant
AU  - Maria Leonor S. Oliveira
PY  - 2026
DA  - 2026/08/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-67702-8
UR  - https://pasteur.hal.science/pasteur-05835783v1
AB  - Streptococcus pneumoniae is a leading cause of lower respiratory tract (LRT) infections and invasive pneumococcal diseases (IPD). Conjugate vaccines are effective against IPD and nasal colonization but offer coverage limited to serotypes included in the formulations. Pneumococcal surface protein A (PspA) stands out as a promising vaccine antigen. We had previously shown that recombinant adenylate cyclase toxoid from Bordetella pertussis (CyaA) carrying PspA fragments induces humoral responses and protection against pneumococcal infection in mice. Here, we present an optimized construct combining fragments derived from four PspA variants (CyaA-A2-A4/A1-A3).Immunization of mice with CyaA-A2-A4/A1-A3 conferred protection against IPD and promoted a rapid control of LRT infection. Antibody reactivity and protection were observed across strains expressing distinct PspAs and capsular serotypes. Importantly, CyaA-A2-A4/A1-A3 protected mice against serotype 3 isolates from clonal complex 180, a major clone causing disease worldwide. CyaA-A2-A4/A1-A3 may be proposed as a complementary vaccine to induce broad protection against pneumococcal infections.
SN  - 2045-2322
ER  -

Abstract

Related

Cite